
IOVA 2-DAY DEADLINE ALERT: Iovance’s (IOVA) CFO Resigns Amid Launch Setbacks and Securities Class Action– Hagens Berman
SAN FRANCISCO, July 12, 2025 (GLOBE NEWSWIRE) -- Biotechnology firm Iovance Biotherapeutics Inc. (NASDAQ: IOVA) announced a significant leadership transition, confirming the resignation of Chief Financial Officer Jean-Marc Bellemin, effective July 10, 2025 …